Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02314754 · ClinicalTrials.gov registry record · Phase 4
Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
A Phase 4 study, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- Phase 4
- Development phase
- 719
- Enrollment target
NCT02314754 is a Phase 4 study that has completed, run by Gynuity Health Projects. The registered enrollment target is 719 participants.
The verdict
NCT02314754, a Phase 4 study, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 719 participants
- Enrollment target
Study Summary
To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48 hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77 days' compared to women 64-70 days' LMP.
Interventions
- DRUG Mifepristone followed by misoprostol 24-48 hours later
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 719 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02314754
The ClinicalTrials.gov registry entry for NCT02314754 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 719 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mifepristone followed by misoprostol 24-48 hours later is the first listed.
NCT02314754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02314754 about?
NCT02314754 is a clinical study titled "Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation". To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48 hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77 days' compared to women 64-70 days' LMP.
What is the current status of trial NCT02314754?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 719 participants. The study started on 2014-12. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02314754?
The interventions under investigation include: Mifepristone followed by misoprostol 24-48 hours later (DRUG).
Who is sponsoring clinical trial NCT02314754?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.